Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

A Compendium of Compounding Agents and Formulations, Part 5: Timolol and Beta-glucans

Author(s):  Riepl Mike

Issue:  Sep/Oct 2022 - Volume 26, Number 5
View All Articles in Issue

Page(s):  364-368

A Compendium of Compounding Agents and Formulations, Part 5: Timolol and Beta-glucans Page 1
A Compendium of Compounding Agents and Formulations, Part 5: Timolol and Beta-glucans Page 2
A Compendium of Compounding Agents and Formulations, Part 5: Timolol and Beta-glucans Page 3
A Compendium of Compounding Agents and Formulations, Part 5: Timolol and Beta-glucans Page 4
A Compendium of Compounding Agents and Formulations, Part 5: Timolol and Beta-glucans Page 5

Download in electronic PDF format for $65

Abstract:  Cutaneous wounds that prove refractory to treatment with commercially manufactured medications impose a burden on patients, create challenges for the clinicians who treat them, and increase the cost of therapy. The success of pharmaceutical wound management and cure depends in part on the degree to which active healing agents are delivered quickly and effectively to injured tissues (factors also affected by the drug[s] and excipients incorporated and skin permeability at the injured site). When an external injury has failed to resolve despite treatment with standardized drug products, a pharmaceutical compound can often provide healing relief. In this report, profiles of and formulations containing timolol (a beta- adrenergic receptor antagonist) and beta-glucans (glucose polymers) are provided. The healing effects of those agents are underrecognized in mainstream medicine, and as a result, they remain underprescribed and unavailable in commercial medications. However, when included in a customized pharmaceutical compound, they can enable and accelerate dermal- wound resolution.

Related Keywords: Mike Riepl, RPh, wound management, wound healing, inflammatory phase, inflammation, timolol maleate, beta-adrenergic receptor antagonist, beta blocker, beta glucans, glucose polymers, dermal wounds, skin permeability, formulations, naltrexone hydrochloride, phenytoin, topical preparations, re-epithelialization, clobetasol proprionate, lidocaine hydrochloride, oral rinse, mucosal administration, venous ulcers, pressure ulcers, mouth ulcers, diabetic ulcers

Related Categories: DERMATOLOGY, DIABETES, FORMULATIONS, WOUND CARE, ALLERGY/IMMUNOLOGY/INFLAMMATION, CARDIOLOGY

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
A Compendium of Compounding Agents and Formulations, Part 5: Timolol and Beta-glucans
Riepl Mike
Sep/Oct 2022
Pg. 364-368

Current Topical Treatments in Wound Healing - Part 1
Helmke Christopher D
Jul/Aug 2004
Pg. 269-274

Options in Wound Care
Kincaid Michele R
Mar/Apr 2002
Pg. 92-95

A Compendium of Compounding Agents and Formulations, Part 6: Additional Preparations for Refractory Dermal-wound Healing
Riepl Mike
Nov/Dec 2022
Pg. 480-488

Compounded Beta-blocker Nasal Spray for Treatment of Acute Migraine: A New Therapeutic Modality
Hagan John C III
, Everett Eric, Chamberlain Tyler
May/Jun 2020
Pg. 194-197

Compounding with Beta-1, 3-D-Glucan
Keller Ted
Sep/Oct 2000
Pg. 342

Simple Preparation of Timolol 0.5% Gel from Eye Drop Solution for Superficial Infantile Hemangiomas
Choo Winnie
Jul/Aug 2017
Pg. 282-289

Infantile Hemangiomas, Part 2: Topical Treatment with Beta Blockers
Zur Eyal
Nov/Dec 2011
Pg. 458-463

Compounding Pearls -- Wound Care: Burn Healing, Part 2
Riepl Mike
Jul/Aug 2020
Pg. 282-285

Y-site Physical Compatibility of Beta-blocker Infusions with Intensive Care Unit Admixtures
Foushee Jaime A
, Meredith Pmichaele, Fox Laura M, Grace EdwardE
Jul/Aug 2016
Pg. 328-332

Compounding Pearls -- Wound Care: Diabetic Foot Ulcers, Part 2
Riepl Mike
Jul/Aug 2020
Pg. 278-281

Compounding Pearls -- Wound Care: Drugs and Formulations for Dermal Healing, Part 2
Riepl Mike
Jul/Aug 2021
Pg. 282-287

A Compendium of Compounding Agents and Formulations, Part 4: Nifedipine and Pentoxifylline
Riepl Mike
Jul/Aug 2022
Pg. 270-274

Palonosetron Hydrochloride Compatibility and Stability with Three Beta-Lactam Antibiotics During Simulated Y-Site Administration
Ben Michel
, Trusley Craig, Kupiec Thomas C, Trissel Lawrence A
Nov/Dec 2007
Pg. 520-524

Compounding Pearls--Wound Care: Drugs and Formulations for Dermal Healing, Part 3: The Roles of Nitric Oxide, Sildenafil, and Naltrexone
Riepl Mike
Sep/Oct 2021
Pg. 372-377

Compounding Pearls -- Wound Care: Burn Healing, Part 1
Riepl Mike
May/Jun 2020
Pg. 188-193

A Compendium of Compounding Agents and Formulations, Part 2: Metronidazole, Misoprostol, and Phenytoin
Riepl Mike
Mar/Apr 2022
Pg. 94-98

Compounding Pearls -- Wound Care: Drugs and Formulations for Dermal Healing
Riepl Mike
Mar/Apr 2021
Pg. 100-103

Timolol 0.125%/Mucolox 15%/0.9% Normal Saline Nasal Spray
Allen Loyd V Jr
Mar/Apr 2023
Pg. 153

Stability of Atenolol, Clonazepam, Dexamethasone, Diclofenac Sodium, Diltiazem, Enalapril Maleate, Ketoprofen, Lamotrigine, Penicillamine-D, and Thiamine in SyrSpend SF PH4 Oral Suspensions
Polonini HC
, Loures S, Lima LC, Ferreira AO, Brandão MA
Mar/Apr 2016
Pg. 167-174